AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$PACS

Murray Jason Hulse sold $441K of PACS

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 8,803 shares of PACS Group, Inc. (PACS) at an average of $50.09 ($50.05–$50.10, $0.44M total) across 2 trades over 2026-10-28 to 2026-10-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Murray Jason Hulse
Published Oct 30, 2026, 11:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PACS
Bearish
medium confidence
Mentioned
$PACS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSBearishLow
01

Why it matters

The CEO's sale, though modest, could prompt short‑term price weakness.

02

Market read

First public disclosure of a CEO‑initiated sale; modest but noteworthy for traders.

03

What to watch

Holding after sale remains large (54M shares), indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: filing today

Background

Form 4 filing discloses insider transactions; investors monitor such sales for signals.

Company-level read

Ticker impact

$PACSBearishMedium confidence
Context

CEO Murray Hulse sold 8,803 shares for $440,913 via a 10b5‑1 plan, reducing his stake.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

The sale is modest in size (<$1M) but involves the CEO, which can influence short‑term sentiment.

Market effects

Sector

Minimal impact on the broader healthcare services sector.

Regional

Limited to U.S. investors tracking PACS.

Global

Low

Counterpoint

What could challenge this read

The sale may be routine under a pre‑arranged plan and not reflect negative outlook.

Key entities

  • person
    Murray Jason Hulse

    Co‑Founder, CEO & Chairman of PACS Group, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PACS insider trading history →

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

finance.yahoo.com
$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

finance.yahoo.com
$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

investing.com